Skip to main content
Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
11.51
+0.72 (6.67%)
At close: Apr 28, 2026, 4:00 PM EDT
11.73
+0.22 (1.91%)
After-hours: Apr 28, 2026, 7:04 PM EDT

Prothena Corporation Revenue

In the year 2025, Prothena Corporation had annual revenue of $9.68M, down -92.84%. Prothena Corporation had revenue of $21.00K in the quarter ending December 31, 2025, a decrease of -99.01%.

Revenue (ttm)
$9.68M
Revenue Growth
-92.84%
P/S Ratio
63.98
Revenue / Employee
$144,537
Employees
67
Market Cap
619.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.68M-125.47M-92.84%
Dec 31, 2024135.16M43.79M47.92%
Dec 31, 202391.37M37.47M69.50%
Dec 31, 202253.91M-146.67M-73.13%
Dec 31, 2021200.58M199.72M23,414.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Rigel Pharmaceuticals 294.28M
Arvinas 262.60M
Zevra Therapeutics 106.47M
Sutro Biopharma 102.48M
Aclaris Therapeutics 7.83M
Prime Medicine 4.63M
Ocugen 4.41M
Revenue Rankings

PRTA News

More News